Lassa virus is estimated to infect several thousand people yearly in West Africa, resulting in many cases of Lassa fever disease associated with high morbidity and lethality. We found that durable cellular immunity exists in many Lassa fever survivors. Though larger studies are needed, these data could help shape vaccine research with a goal of lasting protection with immunization.